733
Views
15
CrossRef citations to date
0
Altmetric
Review

An update of SGLT1 and SGLT2 inhibitors in early phase diabetes-type 2 clinical trials

, , , , , , & show all
Pages 811-820 | Received 22 Apr 2019, Accepted 09 Aug 2019, Published online: 22 Aug 2019

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.